Overview
Intellia is a pioneer in the development of CRISPR/Cas9 genome editing and is rapidly moving experimental therapies towards the clinic.
Our company’s unique strengths include our modular lipid nanoparticle delivery system and our determined focus on product development.
Programs & Pipeline
Each one of us together for patients
We believe our modular approach to selecting our in vivo and ex vivo programs positions us to build a full-spectrum genome editing company, with a pipeline across a range of indications. This approach enables us to generate a wealth of data that opens the potential therapeutic applications of the CRISPR/Cas9 technology across a broad range of diseases.
Full-Spectrum Blog
Today is Intellia’s first ever Career Day! Our various info sessions throughout the day will give employees the opportunity to network and learn more about different functions and the roles our teams play at Intellia. #OneIntellia #IamIntellia #CRISPR #genomeediting https://t.co/WC32S94kBx
Meet Peter, Intellia’s Research Associate and Co-Lead for our Diversity, Equity and Inclusion Cultural Ambassadors Team. Our CA’s host events year-round from volunteer days in the community, to in-house game and trivia nights. https://t.co/DhW4qbBFMy #OneIntellia #CRISPR https://t.co/Ipx5efCis4